Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To assess the safety and reactogenicity of GSK Biologicals’ candidate TB vaccine M72/AS01E in the study population.
Critère d'inclusion
- Vaccination against tuberculosis (TB) in adults aged 18 to 59 years with TB disease